cencora

cencora

Pharmaceutical distribution and healthcare solutions provider

About cencora

Simplify's Rating
Why cencora is rated
A-
Rated A on Competitive Edge
Rated A on Growth Potential
Rated B on Rating Differentiation

Industries

Consulting

Social Impact

Healthcare

Company Size

5,001-10,000

Company Stage

IPO

Total Funding

N/A

Headquarters

Pennsylvania

Founded

1907

Overview

Cencora is a global pharmaceutical solutions organization that focuses on enhancing healthcare for both people and animals. The company provides a wide range of services, including drug distribution, specialty pharmacy services, and consulting, which help healthcare providers, pharmaceutical manufacturers, and veterinary practices improve their operations. Cencora's services also encompass supply chain management, patient support, and data analytics, allowing clients to increase efficiency and reduce costs while improving patient outcomes. Unlike many competitors, Cencora emphasizes a multifaceted business model that generates revenue from various sources, including pharmaceutical distribution and consulting services. The company's goal is to advance pharmaceutical care while also committing to social responsibility through initiatives like Project Black, which aims to foster minority-owned businesses within the healthcare supply chain.

Simplify Jobs

Simplify's Take

What believers are saying

  • Cencora's acquisition of Retina Consultants expands its specialty healthcare services portfolio.
  • The rise of specialty pharmaceuticals boosts demand for Cencora's specialized supply chain services.
  • Increased focus on digital health solutions enhances Cencora's patient engagement and operational efficiency.

What critics are saying

  • The $1.8 billion acquisition of Retina Consultants may strain Cencora's financial resources.
  • Cencora's $75 million ransomware payment highlights significant cybersecurity vulnerabilities.
  • Delaware court case on oversight failures could impact Cencora's governance reputation.

What makes cencora unique

  • Cencora integrates digital solutions to enhance patient engagement and streamline pharmacy operations.
  • The company offers specialized support for managing complex specialty pharmaceutical supply chains.
  • Cencora's FormularyDecisions platform provides centralized access to cell and gene therapy information.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$0

Below

Industry Average

Funded Over

2 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison
Coming Soon

Company News

PYMNTS
Jan 15th, 2025
Good Neighbor Pharmacy’S Tech Rx: Helping Independents Thrive In A Changing Market

Independent pharmacies are adapting to new dynamics, with digital tools and patient expectations changing how they operate and deliver care. Once overshadowed by large chain pharmacies, these independent businesses are finding creative ways to stay competitive by integrating new technologies and expanding their roles beyond traditional dispensing services. Good Neighbor Pharmacy, part of Cencora (formerly AmerisourceBergen), has become a key ally for independent pharmacy owners. The organization provides tools and resources that help members meet modern challenges, from optimizing day-to-day operations to engaging customers and strengthening community relationships. By leveraging digital solutions, Good Neighbor Pharmacy is helping pharmacies remain competitive while continuing to offer trusted healthcare services. Staying True to Its Mission

Stock Titan
Dec 3rd, 2024
Cencora Prices $1.8B Senior Notes Offering to Fund Retina Consultants Acquisition | COR Stock News

Fortune 500 healthcare giant Cencora announces $1.8B in senior notes across three offerings, with rates from 4.625% to 5.150%, to finance Retina Consultants acquisition.

Business Wire
Nov 8th, 2024
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading

Crypto News
Sep 18th, 2024
Cencora paid $75m in Bitcoin ransomware: Bloomberg

The publicly traded drug distributor, formerly known as AmerisourceBergen, reportedly sent Bitcoin btc-1.89% Bitcoin worth $75 million to cyberattackers following a data breach in February.

PR Newswire
Jun 26th, 2024
Dalfen Industrial Sells Two Denver-Area Assets

DALLAS, June 26, 2024 /PRNewswire/ -- Dalfen Industrial has finalized the disposition of two Denver-area assets totaling ~150,000 square feet of industrial space in April 2024. Aurora Center I, Aurora, CO. I-70 Industrial Center was acquired by Dalfen Industrial in August 2019. The industrial center consists of 2 light industrial-warehouse buildings totaling 77,222 SF located in Denver, CO. The property is located in the Upper North Central Industrial Submarket directly off I-70 and just a quarter of a mile from I-25, the region's two major highways. It's also in close proximity to Denver International Airport as well as both the BNSF and Union Pacific Rail Yards

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for cencora right now.

Find jobs on Simplify and start your career today

💡
We update cencora's jobs every 8 hours, so check again soon! Browse all jobs →